Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Ganoderma lucidum extract and its component, ganoderic acid A, may effectively prevent hair loss.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

The nanogel with Ciclopirox Olamine is a promising treatment for skin yeast infections.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Accurate diagnosis is crucial for effectively treating severe alopecia and related symptoms.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Erianin may effectively treat alopecia areata by targeting the immune system.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

M1 homeopathic complex may help slow melanoma cell growth.

ASA and CM may protect the brain and work better together.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.